Poly (ADP-Ribose) polymerase inhibitors (PARPI): Associated thrombosis in patients with ovarian cancer

被引:0
作者
Sanchez Canovas, M. [1 ]
Lopez Robles, J. [1 ]
Garcia Verdejo, F. J. [2 ]
Cacho Lavin, D. [3 ]
Guirao, S. [4 ]
Garrido Fernandez, A. [5 ]
Coma Salvans, E. [6 ]
Quintanar Verduguez, T. [7 ]
Salvador Coloma, C. [8 ]
Fernandez Garay, D. [9 ]
Cumplido, J. D. [10 ]
Ferrer Perez, A. I. [11 ]
Carbo Bague, A. [12 ]
Teigell Munoz, F. J. [13 ]
Munoz Martin, A. J. [14 ]
机构
[1] Hosp Gen Univ Morales Meseguer, Med Oncol Dept, Murcia, Spain
[2] Hosp Univ Jaen, Med Oncol Dept, Jaen, Spain
[3] HUMV Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain
[4] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
[5] Hosp Univ Alvaro Cunqueiro, Med Oncol Dept, Pontevedra, Spain
[6] Hosp Duran & Reynals, ICO Inst Catala Oncol lHospitalet, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[7] Hosp Gen Univ Elche, Med Oncol Dept, Alicante, Spain
[8] Hosp Lluis Alcanyis Xativa, Med Oncol Dept, Valencia, Spain
[9] Hosp Costa del Sol, Agencia Sanitaria Costa del Sol, Med Oncol Dept, Marbella, Spain
[10] Hosp Univ Torrevieja, Med Oncol Dept, Torrevieja, Spain
[11] Obispo Polanco Hosp, Med Oncol Dept, Teruel, Spain
[12] ICO Girona Inst Catala Oncol Girona, Med Oncol Dept, Girona, Spain
[13] Hosp Univ Infanta Cristina, Internal Med Dept, Parla, Spain
[14] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
关键词
D O I
10.1016/j.annonc.2024.08.1955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1861P
引用
收藏
页码:S1095 / S1095
页数:1
相关论文
共 50 条
  • [1] Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions
    Caruso, Giuseppe
    Tomao, Federica
    Parma, Gabriella
    Lapresa, Mariateresa
    Multinu, Francesco
    Palaia, Innocenza
    Aletti, Giovanni
    Colombo, Nicoletta
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 431 - 443
  • [2] Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)
    Durante, Stefano
    Cuccia, Francesco
    Rigo, Michele
    Caminiti, Giovanni
    Mastroleo, Federico
    Lazzari, Roberta
    Corrao, Giulia
    Caruso, Giuseppe
    Vigorito, Sabrina
    Cattani, Federica
    Ferrera, Giuseppe
    Chiantera, Vito
    Alongi, Filippo
    Colombo, Nicoletta
    Jereczek-Fossa, Barbara Alicja
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (08) : 1232 - 1239
  • [3] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
    Liu, Chia-Hao
    Chang, Yi
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
  • [4] Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
    Markman, Maurie
    WOMENS HEALTH, 2018, 14 : 1 - 6
  • [5] Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
    Boussios, Stergios
    Abson, Charlotte
    Moschetta, Michele
    Rassy, Elie
    Karathanasi, Afroditi
    Bhat, Tahir
    Ghumman, Faisal
    Sheriff, Matin
    Pavlidis, Nicholas
    DRUGS IN R&D, 2020, 20 (02) : 55 - 73
  • [6] Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer
    Dong, Ruihong
    Ding, Ting
    Li, Zhengyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
    Stergios Boussios
    Charlotte Abson
    Michele Moschetta
    Elie Rassy
    Afroditi Karathanasi
    Tahir Bhat
    Faisal Ghumman
    Matin Sheriff
    Nicholas Pavlidis
    Drugs in R&D, 2020, 20 : 55 - 73
  • [8] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [9] Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse
    Christina R. Washington
    Kathleen N. Moore
    Current Oncology Reports, 2022, 24 : 1685 - 1693
  • [10] Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse
    Washington, Christina R.
    Moore, Kathleen N.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1685 - 1693